Medicine and Dentistry
Acute Hepatitis
36%
Adeno Associated Virus 2
63%
Antibiotic Therapy
57%
Antibiotics
78%
Antiinfective Agent
31%
Autoantibodies
31%
Bacterial Pneumonia
31%
Biological Marker
78%
Booster Dose
25%
Clinical Decision Making
21%
Clinical Prediction Model
10%
Cohort Analysis
63%
Comorbidity
31%
COVID-19
29%
COVID-19 Vaccination
47%
COVID-19 Vaccine
67%
Cystic Fibrosis
31%
Disease Predisposition
10%
Effect Size
10%
Emergency Care
31%
Enzyme Linked Immunosorbent Assay
31%
Feature Extraction
18%
Human Adenovirus C
10%
Human Herpesvirus 6
15%
Human Leukocyte Antigen
15%
Immune Deficiency
10%
Immunoglobulin G
11%
Immunoreactive Trypsinogen
22%
Independent Reviewer
31%
Informed Consent
31%
Kolmogorov Smirnov Test
31%
Liquid Chromatography-Mass Spectrometry
12%
Logistic Regression Analysis
21%
Myocarditis
31%
Neonates
13%
Newborn Screening
31%
Observational Study
100%
Oxygen Therapy
31%
Partial Least Squares Regression
25%
Pathogen
31%
Patient Assessment
31%
Patient Referral
31%
Physical Development
31%
Prospective Cohort Study
14%
Protocol Compliance
31%
Seasonal Variation
31%
Serositis
31%
Severe Acute Respiratory Syndrome Coronavirus 2
49%
Sweat Test
31%
T Cell
10%
Pharmacology, Toxicology and Pharmaceutical Science
Acquired Immune Deficiency Syndrome
10%
Acute Hepatitis
5%
Adeno Associated Virus 2
31%
Antibacterial Therapy
31%
Antibiotics
78%
Antiinfective Agent
31%
Autoantibodies
31%
Bacterial Pneumonia
31%
Biological Marker
94%
Bronchiolitis
15%
Cohort Study
94%
Comorbidity
31%
COVID-19 Vaccine
99%
Disease Predisposition
10%
Effectiveness Study
6%
Enterovirus
7%
Enzyme-Linked Immunosorbent Assay
31%
Escherichia coli
7%
Helper Virus
5%
HIV
10%
Human Adenovirus C
10%
Immune Deficiency
10%
Immunoglobulin A
6%
Immunoglobulin G
11%
Immunoglobulin M
9%
Infectious Agent
31%
Infectious Complication
10%
Inflammation
31%
Influenza A
7%
Influenza B
7%
Leukocyte Antigen
15%
Mixed Infection
5%
Myocardial Disease
9%
Myocarditis
31%
Neutrophil Gelatinase Associated Lipocalin
6%
Observational Study
68%
Penicillin
9%
Prospective Cohort Study
18%
Respiratory Virus
15%
SARS Coronavirus
81%
Sepsis
6%
Streptococcus Group A
7%
Syndrome
21%
Biochemistry, Genetics and Molecular Biology
Adeno Associated Virus 2
31%
Adenoviridae
5%
Autoantibodies
31%
Blood Plasma
57%
Cohort Study
31%
Cystic Fibrosis
31%
Dideoxynucleotide Sequencing
6%
DNA Analysis
6%
Enzyme
6%
Feature Extraction
31%
Fluorescein Isothiocyanate
10%
Gene Sequence
6%
Genetic Disorder
6%
Glycopeptide
31%
Glycoproteomics
21%
Glycosylation
31%
Human Herpesvirus 6
15%
Immunoassay
6%
Immunofluorescence
5%
Immunoglobulin A
21%
Immunoglobulin G
31%
Immunoglobulin M
26%
Immunoglobulin Variable Region
5%
Immunoreactive Trypsinogen
31%
Infectious Agent
31%
Liquid Chromatography-Mass Spectrometry
21%
Multiplex Ligation-Dependent Probe Amplification
12%
Newborn Screening
31%
Patient Coding
10%
Posttranslational Modification
10%
Protein Expression
10%
Proteome
31%
SARS Coronavirus
36%
T Cell
5%